A tool, developed by the Coalition of Women Living with HIV and AIDS in partnership with Treatment Action Group, designed to equip communities to use community-lead monitoring to better understand the TB screening and diagnostic services, and to translate findings into evidence-based advocacy.
People at risk of tuberculosis (TB) have a right to TB screening and diagnostic testing in accordance with the standard of care recommended by the World Health Organization (WHO). Yet, many countries with high burdens of TB have limited uptake of WHO-recommended tools, such as rapid molecular tests and urine-LAM tests for people living with HIV.
Community-led Monitoring for Access to Tuberculosis Screening and Diagnostic Testing, developed by the Coalition of Women Living with HIV and AIDS (COWLHA) in partnership with Treatment Action Group, is designed to equip communities to use community-lead monitoring (CLM) to better understand the TB screening and diagnostic services they receive; to identify gaps in the availability of tools, services, and care delivered; and to translate findings into evidence-based advocacy. It includes details about TB screening and diagnostic tools that should be available at different levels of the health system, as well as a downloadable CLM data collection tool. Because this CLM framework uses WHO recommendations as the benchmark for the TB standard of care, it can be easily adapted to different countries and settings.
Source: Treatment Action Group